PT  - JOURNAL ARTICLE
AU  - Lackey, Kimberly A.
AU  - Pace, Ryan M.
AU  - Williams, Janet E.
AU  - Bode, Lars
AU  - Donovan, Sharon M.
AU  - Järvinen, Kirsi M.
AU  - Seppo, Antti E.
AU  - Raiten, Daniel J.
AU  - Meehan, Courtney L.
AU  - McGuire, Mark A.
AU  - McGuire, Michelle K.
TI  - SARS-CoV-2 and human milk: what is the evidence?
AID  - 10.1101/2020.04.07.20056812
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.07.20056812
4099  - http://medrxiv.org/content/early/2020/04/11/2020.04.07.20056812.short
4100  - http://medrxiv.org/content/early/2020/04/11/2020.04.07.20056812.full
AB  - The novel coronavirus SARS-CoV-2 has emerged as one of the most compelling public health challenges of our time. To address the myriad issues generated by this pandemic, an interdisciplinary breadth of research, clinical, and public health communities have rapidly engaged to find answers and solutions. One area of active inquiry is understanding the mode(s) of SARS-CoV-2 transmission. While respiratory droplets are a known mechanism of transmission, other mechanisms are possible. Of particular importance to global health is the possibility of vertical transmission from infected mothers to infants through breastfeeding or consumption of human milk. However, there is limited published literature related to vertical transmission of any human coronavirus (including SARS-CoV-2) via human milk and/or breastfeeding. There is a single study providing some evidence of vertical transmission of human coronavirus 229E, a single study evaluating presence of SARS-CoV in human milk (it was negative), and no published data on MERS-CoV and human milk. There are 9 case studies of human milk tested for SARS-CoV-2; none detected the virus. Importantly, none of the published studies on coronaviruses and human milk report validation of their analytical methods for use in human milk. These reports are evaluated here, and their implications related to the possibility of vertical transmission of coronaviruses (in particular, SARS-CoV-2) during breastfeeding are discussed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no funding associated with this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis manuscript represents a review of existing literature, no data has been generated.